Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Theriva Biologics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Theriva Biologics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Monahan John J | Director | – | Jan 6, 2026 | 1 |
| Shallcross Steven A | CEO and CFO | 250,000 | Jan 6, 2026 | 1 |
| Kraws Jeffrey J | Director | – | Jan 6, 2026 | 1 |
| Wolf Jeffrey Alan | Director | – | Jan 6, 2026 | 1 |
| Tufaro Francis | Chief Operating Officer | – | Dec 16, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2023 (view filing) | Jun 7 | 1 day | Shallcross Steven ACEO and CFO | PPurchase | +14.0K | $0.69 | +$9.66K | +5.9%250.0K after | |
| Jun 7, 2023 (view filing) | Jun 6 | 1 day | Shallcross Steven ACEO and CFO | PPurchase | +26.0K | $0.63 | +$16.4K | +12.4%236.0K after | |
| Feb 13, 2023 (view filing) | Feb 10 | 3 days | Shallcross Steven ACEO and CFO | PPurchase | +25.0K | $1.04 | +$26.0K | +13.5%210.0K after | |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Shallcross Steven ACEO and CFO | PPurchase | +25.0K | $0.94 | +$23.5K | +15.6%185.0K after | |
| Jan 26, 2023 (view filing) | Jan 25 | 1 day | Shallcross Steven ACEO and CFO | PPurchase | +25.0K | $0.87 | +$21.8K | +18.5%160.0K after | |
| Jan 23, 2023 (view filing) | Jan 20 | 3 days | Shallcross Steven ACEO and CFO | PPurchase | +25.0K | $0.75 | +$18.8K | +22.7%135.0K after | |
| Jan 3, 2023 (view filing)6:04 AM ET | Dec 29, 2022 | 5 days | Shallcross Steven ACEO and CFO | PPurchase | +100.0K | $0.437 | +$43.7K | +1,000.0%110.0K after |